Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-20-030055
Filing Date
2020-12-31
Accepted
2020-12-31 16:20:56
Documents
7
Effectiveness Date
2020-12-31

Document Format Files

Seq Description Document Type Size
1 S-8 brhc10018560_s8.htm S-8 67602
2 EXHIBIT 5.1 brhc10018560_ex5-1.htm EX-5.1 5059
3 EXHIBIT 23.1 brhc10018560_ex23-1.htm EX-23.1 2902
4 EXHIBIT 99.1 brhc10018560_ex99-1.htm EX-99.1 118987
5 EXHIBIT 99.2 brhc10018560_ex99-2.htm EX-99.2 84160
6 EXHIBIT 99.3 brhc10018560_ex99-3.htm EX-99.3 92971
7 EXHIBIT 99.4 brhc10018560_ex99-4.htm EX-99.4 35017
  Complete submission text file 0001140361-20-030055.txt   407762
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-251855 | Film No.: 201429055
SIC: 2834 Pharmaceutical Preparations